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ABSTRACT 56	
Purpose 57	
There is considerable between subject variation in retinal ganglion cell (GC) density in 58	
healthy individuals, making identification of change from normal to glaucoma difficult. 59	
Ascertaining local cone:GC density ratios in healthy individuals, we wished to 60	
investigate the utility of objective cone density estimates as a surrogate of baseline GC 61	
density in glaucoma patients, and thus a more efficient way of identifying early 62	
changes.  63	
 64	
Design 65	
Exploratory cohort study. 66	
 67	
Participants 68	
Twenty glaucoma patients (60% female) with a median age of 54 years and mean 69	
deviation (MD) in the visual field (VF) of -5 dB and 20 healthy controls (70% female) 70	
with a median age of 57 years and MD of 0 dB were included. 71	
 72	
Methods  73	
Glaucoma patients and healthy subjects underwent in vivo cone imaging at 4 locations 74	
of 8.8° eccentricity with a modified Heidelberg Retina Angiograph HRA2 (scan angle 75	
of 3°). Cones were counted using an automated programme. GC density was 76	
estimated at the same test locations from peripheral grating resolution acuity (PGRA) 77	
thresholds. 78	
 79	
 80	
 81	
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Main Outcome Measures 82	
Retinal cone density, estimated GC density and cone:GC ratios in glaucoma patients 83	
and healthy controls. 84	
 85	
Results 86	
Median [interquartile range, IQR] cone:GC density was 3.51:1 [2.59:1, 6.81:1] in 87	
glaucoma patients compared to 2.35:1 [1.83:1, 2.82:1] in healthy subjects . GC density 88	
was 33% lower in glaucoma patients than in healthy subjects, however cone density 89	
was very similar in glaucoma patients (7,248 cells/mm²) and healthy controls (7,242 90	
cells/mm²).The area under the receiver operator characteristic curve was 0.79 (95% 91	
confidence interval [CI] 0.71-0.86, P<0.001) for both GC density and cone:GC ratio, 92	
and 0.49 (95% CI 0.39-0.58, P=0.79) for cone density. 93	
 94	
Conclusions 95	
Local measurements of cone density do not differ significantly from normal in glaucoma 96	
patients despite large differences in GC density. There was no statistically significant 97	
association between GC density and cone density in the normal participants, and the 98	
range of cone:GC density ratios was relatively large in healthy controls. These findings 99	
suggest that estimates of baseline GC density from cone density are unlikely to be 100	
precise, and offer little advantage over determination of GC alone in the identification 101	
of early glaucomatous change. 102	
 103	
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Introduction 107	
Between-individual variability in retinal ganglion cell (GC) density in healthy human 108	
eyes is known to be high.1 As a result, when a patient suspected of having glaucoma 109	
presents for the first time, it is difficult to determine whether a clinical measurement 110	
relating to GC density (e.g., conventional perimetry, peripheral grating resolution acuity 111	
[PGRA], or imaging parameter) is normal for the individual or already represents a 112	
change from that individual’s original baseline. If, however: a) the cone:GC ratio is 113	
relatively similar between normal individuals (despite large inter-individual variation in 114	
both cone and GC density), and b) the number of cones remains stable in glaucoma 115	
(despite a decline in GC density), then objective cone density measures could be used 116	
as a means to determine the original baseline GC density and thus help to identify 117	
early GC loss in glaucoma without a lengthy longitudinal investigation.  118	
While the death of retinal GC is a hallmark of glaucoma, the notion of a loss of 119	
cones in glaucoma is somewhat controversial. A loss of cones has been reported in 120	
several studies2-5, but this has not been confirmed in other studies.6, 7 With the 121	
introduction and development of adaptive optics (AO) technology, in vivo imaging of 122	
retinal structures at cellular level has become possible.8 More recently, Wolsley et al 123	
demonstrated that, by  narrowing the scan width of the Heidelberg Retina Tomograph 124	
(HRT), the parafoveal photoreceptor mosaic may be imaged in vivo with a 125	
commercially available clinical device, without the need for AO.9 Similarly, images of 126	
the retinal cones can also be obtained in vivo using a modified Heidelberg Retina 127	
Angiograph 2 (HRA2), in a patient-friendly clinical setting.   128	
In this study we used measurements of PGRA10 to estimate GC density at 129	
various locations outside the fovea. We also used a modified, small-angle HRA2 to 130	
image retinal cones in vivo at the same locations. By separately measuring cone and 131	
GC density at identical locations in both healthy subjects and glaucoma patients we 132	
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wished to a) explore the possibility of estimating what was the local baseline GC 133	
density in glaucoma patients from in vivo measurements of cone density using normal 134	
cone:GC density ratios , b) establish between-individual variability in cone:GC density 135	
in healthy observers, and c) investigate the utility of cone:GC density ratios in the 136	
identification of glaucoma. 137	
 138	
Methods 139	
Participants 140	
The study protocol was approved by both the relevant National Health Service 141	
Research Ethics Committee and the UCL Research Ethics Committee. The research 142	
followed the tenets of the Declaration of Helsinki and written informed consent was 143	
obtained from all participants prior to inclusion. 144	
 Twenty open-angle glaucoma patients with a median age of 54 years and mild 145	
to moderate, mainly localized, visual field loss (median [IQR]: mean deviation (MD), -146	
5 dB [-9, -4]; pattern standard deviation (PSD), 8 dB [6, 10]), and 20 age-similar healthy 147	
controls with a median age of 57 years underwent in vivo cone imaging with a HRA2 148	
in addition to co-localized estimates of PGRA and differential light sensitivity (DLS). 149	
Inclusion criteria for glaucoma patients were: a diagnosis of open-angle glaucoma 150	
(including normal tension glaucoma), ‘outside normal limits’ readings for optic disc 151	
imaging according to Moorfields Regression Analysis using Heidelberg Retina 152	
Tomograph (HRTII; Heidelberg Engineering GmbH, Heidelberg, Germany) and overall 153	
or focal loss of peripapillary retinal nerve fibre layer (RNFL) in optical coherence 154	
tomography imaging (Spectralis OCT, Heidelberg Engineering GmbH, Heidelberg, 155	
Germany), in addition to a confirmed glaucomatous visual field defect as determined 156	
by standard automated perimetry (SAP) with the Humphrey Field Analyzer (HFAII; Carl 157	
Zeiss Meditec, Dublin, CA) 24-2 Swedish Interactive Threshold Algorithm (SITA) 158	
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strategy. A glaucomatous visual field defect was defined as a reduction in sensitivity 159	
at two or more contiguous locations with P < 0.01 loss or more, three or more 160	
contiguous points with P < 0.05 loss or more.11 Inclusion criteria for healthy subjects 161	
were ‘within normal limits’ results for optic disc imaging (HRTII and OCT) and a full 162	
visual field. Subjects with a reliable visual field with fewer than 30% fixation losses and 163	
less than a 15% false-positive rate were included. All subjects had intraocular pressure 164	
(IOP) <21 mmHg, refractive error <6.00 DS and <1.50 DC, and visual acuity (VA) of 165	
20/30 (6/9) or better in the test eye, in the absence of significant corneal or media 166	
opacities. Exclusion criteria were the evidence of any systemic disease or medication 167	
which affects visual performance (e.g. diabetes, thyroid disease), any ocular disease 168	
(other than glaucoma for the glaucoma group), and surgery that may affect visual 169	
performance (e.g. resulting in poor visual acuity, refractive error outside above stated 170	
range). 171	
 After completion of preliminary tests, in vivo cone imaging with a modified small-172	
angle HRA2, localized measurements of DLS and PGRA to estimate GC density, and 173	
thickness measurement of the ganglion cell layer (GCL) were performed as described 174	
below. One experienced operator (JM) performed all tests. If both eyes met inclusion 175	
and exclusion criteria in glaucoma patients and normal controls, the right eye was 176	
chosen.  177	
 178	
Psychophysical tests 179	
Peripheral Grating Resolution Acuity (PGRA) 180	
PGRA was measured in the corresponding visual field locations with achromatic Gabor 181	
patches in sine phase (SD x Spatial frequency: 4; Michelson contrast: 99%; mean 182	
luminance: 30 cd/m2), presented on a uniform 30 cd/m2 grey background varying in 183	
spatial frequency. Experiments were undertaken on a gamma-corrected Phillips FIMI 184	
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MGD-403 Achromatic CRT monitor (Ampronix, Irvine, CA, USA; refresh rate: 80 Hz, 185	
pixel resolution: 976 x 1028), driven by a Visual Stimulus Generator (ViSaGe MKII, 186	
Cambridge Research Systems, Rochester, UK) and the Cambridge Research Systems 187	
(CRS) toolbox (version 1.27) for MATLAB (R2014b, The MathWorks Inc., Natick, MA). 188	
Reponses were collected using a Cedrus RB-530 response box (Cedrus Corporation, 189	
San Pedro, CA, USA). Participants were asked to view a cross-hair fixation target on 190	
the CRT monitor at a viewing distance of 60 cm and report whether the grating, 191	
presented at 8.8° eccentricity along the 45°, 135°, 225° and 315° meridians for 500 192	
ms, was orientated either horizontally (180º) or vertically (90º). Resolution acuity was 193	
determined using a 3/1 reversal strategy, taking the average of four reversals, where 194	
the first two reversals resulted in a spatial frequency change of 20%, the third reversal 195	
a 10% change and the final reversal 5% change. Gabor patches scaled in size to 196	
maintain a constant number of high contrast cycles within the patch at all times to 197	
optimize resolution performance.12 All subjects were optically corrected for the test 198	
distance and the eye not being tested was occluded. Resolution acuity values were 199	
then converted from minimum angle of resolution (MAR) to GC density (D, in GC/mm2) 200	
using the equation MAR = 0.93/√D for a hexagonal array.13 A conversion factor from 201	
Drasdo & Fowler14 was used to calculate the number of GCs per square millimeter of 202	
the retina. 203	
 204	
Differential light sensitivity (DLS) 205	
Contrast thresholds were measured for an approximate Goldmann III size achromatic 206	
stimulus (0.48°, 0.18 deg2) of duration15 191.9 ms at the same visual field locations 207	
(8.8° eccentricity along the 45°, 135°, 225° and 315° meridians). Stimuli were 208	
generated with a ViSaGe MKII and the CRS toolbox for MATLAB. Participants were 209	
instructed to view the central fixation target and press a button on a response pad 210	
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(Cedrus RB-530) when a stimulus was seen. A randomly interleaved 1/1 staircase 211	
(step size 0.5 dB of the previous value) terminating after six reversals was used, with 212	
threshold contrast being calculated as the mean of the final four reversals. Contrast 213	
thresholds were expressed in Humphrey equivalent dB values. 214	
 215	
In vivo cone imaging using a modified small-angle HRA2 216	
A standard HRA2 (Heidelberg Engineering GmbH, Heidelberg, Germany) was 217	
modified for high resolution imaging of the fundus. For this purpose the scan angle was 218	
reduced by a factor of 10x to image fields of view of 3°, 2° and 1.5°, while the total 219	
number of pixels remained unchanged. This resulted in an oversampling of the 220	
diffraction limited spot size with the cone mosaic becoming visible (Fig 1 A, B). The 221	
images were acquired using a diode laser emitting at 815 nm working under reflection 222	
mode. The laser power was confirmed to be safe without restrictions, according to 223	
International Electrotechnical Commission (IEC) 60825-1:2007. To assess different 224	
areas of the fundus, the internal fixation lights could be adjusted manually by means 225	
of externally accessible alignment tools. In vivo imaging of the retinal cone mosaic was 226	
performed at four retinal locations (inferior nasal, inferior temporal, superior nasal, 227	
superior temporal retina) at 8.8° eccentricity along the 45°, 135°, 225° and 315° retinal 228	
meridians, through undilated pupils with room lights on (Fig 1 C, D). Subjects were 229	
instructed to look at the center of one of the cross-hair fixation targets, positioned at 230	
one of four pre-determined locations relative to the scan window, to enable imaging at 231	
the desired locations. Single, non-averaged en face reflectance images were collected 232	
and analyzed. The field of imaging was 3° × 3°, equating to 0.825 x 0.825 mm on the 233	
retina, based on Drasdo and Fowler’s conversion for the relevant retinal location.14  234	
 235	
 236	
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Image analysis  237	
Raw images of the cone mosaic (~3° x 3°, 768 x 768 pixels) were initially cropped to 238	
remove any extraneous features (e.g., scale bar, company logo, etc.). Cones were 239	
then identified in the cropped image (~2.89° x 2.89°, 740 x 740 pixels) by the method 240	
of Li & Roorda16, in MATLAB (R2014b) with the image processing toolbox (IPT). Briefly, 241	
this analysis first applies a low-pass filter in the frequency domain to the image to 242	
remove high-frequency noise from the image. Following this, the image is converted 243	
back to the spatial domain and the local luminance maxima detected using the IPT 244	
function imregionalmax. These identified regions were assumed to be cone centers 245	
and were plotted as single white pixels on a black background. To ensure the identified 246	
cones were not closer than physiologically possible, the binary blobs were each dilated 247	
using a white disk of diameter 2 pixels (i.e., if inter-cone spacing were too small, the 248	
given identified cones would no longer be spatially independent following dilation). 249	
Following this, each remaining spatially independent blob was counted as a cone. This 250	
value was then converted to a density value expressed as cones/mm2. This method 251	
has been shown to provide cone density estimates that are very similar to those 252	
determined through manual counts, with the spatial localization of identified cones also 253	
being accurate for images acquired with AO technology.16 Figure 2 shows an example 254	
of the worst, typical and best quality image we captured in our participants and the 255	
automated cone count of the scan with the best quality. 256	
 257	
Ganglion cell layer thickness 258	
Automated segmentation and thickness measurement of the GCL was performed on 259	
the posterior pole scans (Spectralis OCT, acquisition software version 5.7.4.0). The 260	
grids on the posterior pole GCL thickness scans were rotated and translated to align 261	
with individual cone images (squares of grid also 3° × 3°, Fig 3). 262	
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 263	
Statistical analysis 264	
Statistical analyses were performed with SPSS 23 (IBM Corporation, Armonk, NY, 265	
USA) and R (version 3.0.0, The R project). Median [interquartile range, IQR] GC and 266	
cone densities (cells/mm²), and cone:GC ratios, were calculated for glaucoma patients, 267	
and compared with those in age-similar healthy controls. A Mann-Whitney U test was 268	
used to test for statistically significant differences between groups and Friedman’s two-269	
way analysis of variance between locations within groups. Linear regression analysis 270	
was used to investigate the relationship between cone and GC density, cone:GC ratio 271	
and GCL thickness (from OCT) to corresponding DLS values (expressed in Humphrey 272	
equivalent dB values). Cone and GC density and GCL thickness were converted to log 273	
values for comparison with DLS. Receiver operator characteristic (ROC) curves and 274	
associated area under the receiver operator characteristic curve curve (AUROC) 275	
values were used to compare cone:GC ratio, GC density and cone density for 276	
diagnostic accuracy in the detection of glaucoma. Sixty-nine of 80 locations in 277	
glaucoma patients and 75 of 80 locations in healthy controls were included in the 278	
analysis. Scans where no cones could be resolved by eye were excluded from 279	
analysis. Glaucoma was seen as the positive test result. The ROC curves were used 280	
to estimate the sensitivity of GC density and cone:GC ratio at set specificities of 80% 281	
and 90%. For all analyses listed, a P value of <0.05 was considered statistically 282	
significant. To avoid type I errors we performed a Holm-Bonferroni correction where a) 283	
there were multiple tests of the same hypothesis (e.g. testing statistical significance of 284	
differences between data in superior and inferior hemifields) and b) p-values for 285	
individual tests are less than 0.05.  286	
  287	
 288	
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Results 289	
General characteristics of glaucoma patients and age-similar healthy controls are 290	
given in Table 1. There was no statistically significant difference between each group 291	
in terms of age, gender, visual acuity, spherical refractive error or IOP (all P > 0.05).  292	
 293	
GC density, cone density and cone:GC ratio 294	
 Median GC density was 33% lower in glaucoma patients than in healthy 295	
subjects over all tested locations. GC density was significantly reduced in glaucoma 296	
patients compared to that in healthy controls in the inferior retinal hemified (P < 0.001, 297	
Table 2). Figure 4 shows the fundus image of a glaucoma patient with a paracentral 298	
scotoma in the superior visual field and corresponding reduced RNFL thickness and 299	
GC density in the inferior retina. 300	
There was no statistically significant difference in cone density between 301	
glaucoma patients and healthy controls in either retinal hemifield (superior: P = 0.48, 302	
inferior: P = 0.69). Median cone density was very similar between glaucoma patients 303	
and healthy controls (glaucoma patients: 7,248 cells/mm², healthy controls: 7,242 304	
cells/mm²; Table 2). There was no statistically significant inter-location difference in 305	
cone density within each group (glaucoma: P = 0.44; healthy controls: P = 0.75). 306	
 Cone density and GC density were not significantly associated in either 307	
hemifield in the healthy or glaucomatous  group (Fig 5 A, C). There was a statistically 308	
significant relationship between DLS and log estimated GC density in both retinal 309	
hemifields in glaucoma patients (superior: R² = 0.59, P < 0.001; inferior: R² = 0.28, P 310	
< 0.001, Fig 5 B, D). There was no statistically significant relationship between DLS 311	
and log cone density in either group.  312	
Median cone:GC density ratio was 3.51:1 (IQR: 2.59:1, 6.81:1) in glaucoma 313	
patients compared to 2.35:1 (IQR: 1.83:1, 2.82:1) in healthy subjects (Table 2, Fig 5 314	
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E). Ratios were significantly higher in the glaucoma patient group, compared to those 315	
in the healthy subject group (P < 0.01). Cone:GC ratios were not significantly different 316	
in the superior locations (without glaucomatous defect of the corresponding inferior 317	
hemifield) between glaucoma patients and healthy subjects (P > 0.05, Table 2). 318	
Cone:GC density ratios showed a large range in healthy controls (Fig 5 E). In view of 319	
this, attempting to calculate the true baseline GC density from in vivo measurements 320	
of cone density from healthy controls would be imprecise. The coefficient of variation 321	
was 30% for cone:GC ratio and 33% for GC density.  322	
 323	
Separation of cone:GC ratio and GC density to diagnose glaucoma 324	
Figure 6 illustrates the ROC curve for GC and cone density and cone:GC ratio. AUROC 325	
was 0.79 (95% confidence interval [CI] 0.71-0.86, P < 0.001) for both GC density and 326	
cone:GC ratio.Specificity was set to 80% and 90% and sensitivity was then derived. At 327	
a specificity of 80%, sensitivity was 62% for GC density (with cut-off value of 2,425 328	
GCs/mm²) and 59% for cone:GC ratio (with cut-off values of 3.04:1). At a set specificity 329	
of 90%, sensitivity was 44% for GC density (1,935 GCs/mm²) and 49% for cone:GC 330	
ratio (3.59:1). 331	
 332	
Ganglion cell layer thickness 333	
GCL thickness was reduced in glaucoma patients compared to healthy controls in the 334	
area corresponding to visual field defects. The greatest GCL thickness loss across all 335	
of our patients was in the inferior retina (corresponding to superior hemifield on visual 336	
field). Median GCL thickness at test locations in glaucoma patients was 23 µm, 337	
significantly thinner than that in healthy controls (31 µm, P < 0.001, Table 2). No 338	
correlation was found between cone density and GCL thickness at any location in 339	
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either group (Spearman’s ρ 0.02, P = 0.81). There was a significant linear relationship 340	
between DLS and GCL thickness (R² = 0.52, P < 0.001). 341	
 342	
Discussion 343	
The findings of this study lend support to the notion that although GC density is 344	
significantly reduced in glaucoma patients relative to that in healthy controls, cone 345	
density is not. The ratio of cones and overlying GCs is therefore increased in our 346	
participants with glaucoma. One of the aims of this study was determine the utility of 347	
cone imaging in the calculation of baseline GC density for more efficient identification 348	
of GC loss. The moderately large range of cone:GC density ratios in healthy controls 349	
(Fig 5 E) leads us to conclude that any prediction of baseline GC density from objective 350	
measures of cone density would be imprecise and offer little superiority over 351	
conventional methods in the identification of early glaucomatous loss.  352	
Despite finding no statistically significant difference in cone density overall in the 353	
glaucoma patients recruited to the current study, it was still considered possible that 354	
by combining information on local cone and GC density in each patient may offer 355	
advantages over and above density alone for the identification of glaucomatous retinal 356	
damage. However, we did not find a statistically significant relationship between cone 357	
and GC density in patients or controls. Furthermore, the qualitative and quantitative 358	
(AUROC) similarity in the ROC curves for cone:GC ratio and GC density alone, further 359	
demonstrates that there is little advantage in combining cone and GC density 360	
estimates in each patient.  361	
This is the first study to compare estimates of cone density, derived from in vivo 362	
images of the photoreceptor mosaic captured with an Heidelberg Retina Angiograph 2 363	
(HRA2) without adaptive optics (AO), and psychophysical estimates of ganglion cell 364	
density and function in corresponding regions. The retinal cone density agreed 365	
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reasonably well with previously published studies using histological data17, 18, AO 366	
imaging19-21 and imaging with a modified first-generation Heidelberg Retina 367	
Tomograph9.  368	
 Although glaucoma is a degenerative optic neuropathy affecting ganglion cells 369	
and their axons, previous studies investigating the involvement of the outer retina, 370	
including photoreceptors, in the disease have yielded somewhat conflicting results. 371	
Structural2-5 changes of the outer retina in glaucoma have been reported by some 372	
histological and clinical studies but not by others.6, 7 Studies involving tests of colour 373	
vision and electrophysiology have reported reduced function, suggestive of outer 374	
retinal layer abnormalities in glaucoma.22-27 Vincent et al have shown a dysfunction of 375	
cone photoreceptors in the central 24° visual field in advanced glaucoma using 376	
multifocal electroretinogram.27 Cone densities presented in our study were not 377	
significantly different between glaucoma patients with visual field loss ranging from 378	
mild to moderate and age-similar healthy controls. We have included predominantly 379	
glaucoma patients with paracentral defects (within 10° of fixation) but did not find cone 380	
loss at 8.8° in glaucoma. Choi and colleagues found evidence of cone loss in glaucoma 381	
using AO imaging.2 A shortening of the cone outer segments was seen with AO in 382	
areas corresponding to reduced visual sensitivity. The authors concluded that this may 383	
explain dark patches observed in AO en face retinal images. This is in line with a study 384	
conducted by Werner et al on outer retinal changes in glaucomatous and non-385	
glaucomatous optic neuropathies observing that cones were less reflective in 386	
corresponding areas of visual field defect, resulting in dark regions in the en face AO 387	
images and accompanying disruptions in the outer retinal layers.5 Although number of 388	
cones did not differ between areas of normal and depressed visual sensitivity among 389	
glaucoma patients, and also between healthy subjects and glaucoma patients in our 390	
study, we have seen dark areas where cones could not be resolved in a number of 391	
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patients. For example, they can be observed in the inferior retina corresponding to a 392	
dense superior hemifield defect in a 47 year-old glaucoma patient (Fig 7 as 393	
supplemental data).  394	
In this study, median cone density at 8.8° (2.42 mm) retinal eccentricity was 395	
7,248 cells/mm² in glaucoma patients and 7,242 cells/mm² in healthy controls . These 396	
cone density estimates are somewhat lower than those reported in some histological 397	
studies (e.g. Curcio et al17) or from some in vivo studies using AO imaging devices.19-398	
21 Curcio et al reported cone counts of approximately 9700 cones/mm² at ~ 2.5 mm 399	
retinal eccentricity in 8 eyes of 7 healthy, adult human donors (age 27-44 years).17 An 400	
AO imaging study conducted by Song and colleagues found a cone density of 401	
approximately 8600 cells/mm² at ~ 2.6 mm retinal eccentricity in healthy participants 402	
aged 22-65 years.21 Wolsely et al used a modified HRT to image cones in 2 healthy 403	
subjects and found a cone density of 7000 cones/mm² at ~ 2.3 mm eccentricity 404	
(extrapolated from values presented) and compares well to our data.9 However, Jonas 405	
et al reported a lower cone density of 6000 cones/mm² at only 1.5 mm (~ 5°) retinal 406	
eccentricity in 21 normal human donor eyes with a mean age of 47 ± 22 years (range 407	
2–90 years).18 Inter-study variations in the age and refractive error of participants, in 408	
addition to possible eccentricity changes as a result of flat-mounting in histological 409	
studies, may partially account for any differences in cone density reported in the 410	
literature with those in this study. Another potential source of variability influencing 411	
reported cone densities relate to the factor used for the conversion of millimetres to 412	
degrees on the retina, along with nuances in the analysis methods applied to generate 413	
cone counts. The algorithm used for automated cone counting in this study was, 414	
however, based on work previously reported for cone images with AO devices.16,20 415	
These reports found a good agreement between automated and manual counting 416	
analysis methods. 417	
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 Limitations of our study must be discussed. First, as this was an exploratory 418	
study, only a small number of participants was included. Second, while we did not 419	
adjust for GC displacement relative to their corresponding photoreceptors, the 420	
displacement of GCs decreases with eccentricity and is reported to be negligible (2.34 421	
mm) for cones at 2.42 mm (8.8°) eccentricity using the equation y = 1.29 x [x + 0.046]0.67 422	
(y = GC eccentricity; x = cone eccentricity) from Sjöstrand et al.28 Third, some images 423	
(11 of 80 glaucoma and 5 of 75 normal) were excluded from analysis where cones 424	
could not be identified, either owing to optical limitations (e.g. poor tear film, higher 425	
astigmatism or unsteady fixation) or some, as yet, unknown change in the retina (e.g. 426	
refractive index changes).  427	
 In conclusion, our results did not show any notable advantage in using cone: 428	
GC ratios over GC density alone for identifying glaucoma. Cone:GC density ratios and 429	
GC densities show a relatively large range even in healthy controls and no relationship 430	
was found between cone and GC density in either group. On this basis, we conclude 431	
that measurements of cone density are unlikely to be helpful in the estimation of local 432	
baseline GC density in a first-time patient.   433	
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FIGURE LEGENDS 500	
 501	
Figure 1. Schematic view of a Modified Heidelberg Retina Angiograph 2 (HRA2).  502	
A and B – Small-angle principle of a modified HRA2. Standard 30° (top) and modified 503	
small-angle 3° principle (bottom). In vivo cone imaging was performed at 4 retinal 504	
locations at approximately 8.8° retinal eccentricity.  505	
C and D – Small-angle retinal scan with a scan angle of 3° (cropped to ~2.89° x 2.89°, 506	
740 x 740 pixels) of a 58 year-old healthy control and superimposed onto fundus 507	
image. 508	
 509	
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Figure 2. Examples of cone scans. 510	
Worst (A), typical (B) and best quality (C) images of the retinal cone mosaic (D – 511	
automated cone count; note few cones were counted in blood vessels). All images 512	
were cropped to 740 x 740 pixels. 513	
 514	
 515	
 516	
 517	
 518	
 519	
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Figure 3. Adjustment of ganglion cell layer thickness measurement. 520	
A – False-color thickness map displays thickness measurement of ganglion cell layer 521	
(GCL).  522	
B – The posterior pole grid was subsequently adjusted such that the external border 523	
of the grid was parallel with the edge of the fundus image and the overlay transparency 524	
adjusted to visualize landmarks (e.g. blood vessels).  525	
C – The grid was then moved to coincide with the position as of the cone image(s) 526	
captured (D) to produce GCL thickness values in the retinal regions examined. 527	
 528	
 529	
 530	
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Figure 4. Fundus of a 60 year-old female patient with normal tension glaucoma. 531	
Inferior ganglion cell (GC) loss and corresponding superior field defect (pattern 532	
deviation plot). Reduced GC density and respective increased cone:GC ratio in the 533	
inferior retina. 534	
 535	
 536	
 537	
 538	
 539	
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Figure 5. Relationships between local cone density, ganglion cell (GC) density and 540	
differential light sensitivity (DLS).  541	
A, C – Relationship between local cone and GC density in the superior (A) and inferior 542	
(C) retinal hemifields of glaucoma patients and controls 543	
B, D – Relationship between local cell (cone and GC) density and differential light 544	
sensitivity (DLS) in glaucoma patients and controls. Boxes indicate the 95% confidence 545	
intervals for cell density (height) and DLS (width) in healthy controls. 546	
E – Range of cone:GC ratios in glaucoma patients and healthy controls. 547	
 548	
 549	
 550	
 551	
 552	
 553	
 554	
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Figure 6. Receiver operating characteristic (ROC) curve for separation of ganglion cell 555	
(GC) and cone density, and cone:GC ratio to detect glaucoma. 556	
Area under the ROC curve (AUROC) was 0.79 (95% confidence interval [CI] 0.71-557	
0.86) for both GC density and cone:GC ratio. Sixty-nine locations of glaucoma patients 558	
were included and compared to 75 locations of healthy controls.  559	
 560	
 561	
 562	
 563	
 564	
 565	
 566	
 567	
 568	
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Figure 7. Example of a 47 year-old female patient with normal-tension glaucoma.  569	
A – A large area of inferior ganglion cell (GC) loss and corresponding dense superior 570	
field defect (pattern deviation plot) are evident (nerve fibre bundle defect marked with 571	
black lines).  572	
B – Raw cone images for all 4 locations (cropped to ~2.89° x 2.89°, 740 x 740 pixels). 573	
Note blurred scans in the inferior retina with advanced retinal nerve fiber and ganglion 574	
cell loss (black arrows show dark patches where cones cannot be resolved). 575	
 576	
 577	
 578	
 579	
 580	
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Table 1. Demographic Data of Glaucoma Patients and Healthy Participants 
 Healthy Glaucoma P value 
n of eyes/participants 20/20 20/20  
Age, years 57.00 [51.25, 63.75] 54.00 [50.25, 59.75] 0.58 
Sex   0.74 
   male 6 (30) 8 (40)  
   female 14 (70) 12 (60)  
Eye   1.00 
   right 16 (80) 15 (75)  
   left 4 (20) 5 (25)  
BCVA, Snellen   0.06 
    6/5 20 (100) 15 (75)  
    6/6 0 (0) 4 (20)  
    6/9 0 (0) 1 (5)  
Spherical error, DS +0.50 [-1.25, +0.94] +0.13 [-1.38, +0.94] 0.68 
Astigmatism, DC -0.25 [-0.50, +0.00] -0.75 [-1.00, -0.50] 0.003 
IOP, mmHg 14.5 [13.3, 16.0] 13.0 [11.0, 15.0] 0.07 
RNFL thickness, µm 98.0 [92.0, 102.0] 68.5 [57.8, 78.0] <0.001 
Data are absolute vales (%), median [interquartile range] as appropriate. 
Abbreviations: BCVA best-corrected visual acuity, DC dioptre cylinder, DS dioptre sphere, IOP 
intraocular pressure, MD mean defect, n number of eyes/participants, PSD pattern standard 
deviation, RNFL retinal nerve fiber layer. 
 
	581	
 582	
 583	
 584	
 585	
 586	
 587	
 588	
 589	
 590	
 591	
 592	
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Table 2. Cone Density, estimated GC Density and Cone:GC Ratio, GCL Thickness 
and Visual Sensitivity at different retinal locations 
 Healthy Glaucoma P value 
GCs/mm²    
   superior nasal 3023 [2550, 3713] 2483 [1995, 3119] 0.06 
   inferior nasal 2885 [2200, 3314] 971 [727, 2099] <0.001 
   superior temporal 3325 [2441, 4301] 2684 [2262, 3166] 0.09 
   inferior temporal 3373 [2670, 4034] 1458 [727, 2252] <0.001 
   All locations 3158 [2503, 4060] 2125 [971, 2763] <0.001 
Cones/mm²    
   superior nasal 7295 [6845, 7763] 7196 [6972, 7499] 0.91 
   inferior nasal 7213 [6842, 7777] 7332 [7082, 7965] 0.32 
   superior temporal 7098 [6996, 7352] 7238 [6968, 7685] 0.55 
   inferior temporal 7432 [6814, 7630] 7215 [6700, 7495] 0.39 
   All locations 7242 [6876, 7700] 7248 [6968, 7634] 0.79 
Cone:GC ratio    
   superior nasal 2.43:1 [1.78:1, 
2.76:1] 
2.94:1 [2.25:1, 4.44:1] 0.08 
   inferior nasal 2.48:1 [2.15:1, 
3.34:1] 
6.76:1 [3.73:1, 10.78:1] <0.001 
   superior temporal 2.13:1 [1.72:1, 
2.02:1] 
2.73:1 [2.22:1, 3.60:1] 0.07 
   inferior temporal 2.18:1 [1.81:1, 
2.56:1] 
5.24:1 [3.01:1, 10.45:1] <0.001 
   All locations 2.35:1 [1.83:1, 
2.82:1] 
3.51:1 [2.59:1, 6.81:1] <0.001 
GCL thickness, µm    
   superior nasal 31.0 [30.0, 33.0] 27.5 [22.0, 32.8] 0.08 
   inferior nasal 30.0 [29.0, 32.0] 21.0 [19.0, 23.5] <0.001 
   superior temporal 32.0 [29.0, 34.0] 29.0 [24.0, 32.0] 0.06 
   inferior temporal 32.5 [28.8, 35.0] 20.0 [17.0, 23.0] <0.001 
   All locations 30.8 [29.1, 33.3] 23.3 [21.0, 27.5] <0.001 
Visual sensitivity, dB†    
   superior nasal 32.7 [31.3, 33.2] 29.9 [28.6, 32.5] 0.005 
   inferior nasal 32.1 [31.3, 32.8] 24.5 [17.2, 27.5] <0.001 
   superior temporal 32.4 [31.5, 33.1] 31.3 [30.1, 32.8] 0.03 
   inferior temporal 31.8 [31.1, 32.1] 25.3 [20.5, 28.7]  <0.001 
   All locations 32.1 [31.4, 32.9] 28.6 [24.4, 30.9] <0.001 
Data are median [interquartile range] retinal locations at ~ 8.8° eccentricity. 
Abbreviations: GC ganglion cell, GCL ganglion cell layer, n number of locations,. 
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Note: Not all of the 4 locations for each glaucoma patient or healthy participant could be imaged 
with some locations therefore excluded. The majority of images (> 80%, 75 images included/80 total 
number of locations in healthy subjects and 69/80 in glaucoma patients) were, however, analyzed. 
In bold, significantly reduced GC density and visual field sensitivity, and increased cone:GC ratio 
mainly in the inferior retina. Cone count remains constant over all locations. Most of the glaucoma 
patients (90%) had glaucomatous defects in the superior hemifield. 
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